Daesung Microbiological Labs. Co., Ltd. (KOSDAQ:036480)
South Korea flag South Korea · Delayed Price · Currency is KRW
7,390.00
+40.00 (0.54%)
At close: Feb 13, 2026

KOSDAQ:036480 Balance Sheet

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash & Equivalents
3,8053,6304,3623,8524,3955,212
Short-Term Investments
4,4325,4237,3659,0075,5394,840
Cash & Short-Term Investments
8,2389,05311,72712,8599,93510,052
Cash Growth
-11.56%-22.80%-8.80%29.44%-1.17%-19.61%
Accounts Receivable
4,8643,7794,1313,0402,9863,675
Other Receivables
133.05178.67154.12155.3771.9654.86
Receivables
4,9973,9584,2853,1963,0583,730
Inventory
11,31910,48112,49911,64110,6149,197
Prepaid Expenses
99.93106.25171.0735.2632.9615.23
Other Current Assets
7.3742.7734.1958.9782.36163.6
Total Current Assets
24,66123,64128,71728,69023,72223,757
Property, Plant & Equipment
30,54631,94432,12433,30335,84635,285
Long-Term Investments
1,4761,3101,4981,2561,3271,346
Other Intangible Assets
355.17354.8356.77354.83356.3358
Long-Term Deferred Tax Assets
341.06574.44734.47134.47355.46374.75
Long-Term Deferred Charges
103.82192.79330.08518.86717.28846.22
Other Long-Term Assets
388.07361.62530.37852.47295.71295.71
Total Assets
57,87258,37964,29065,10962,62062,263
Accounts Payable
1,1621,3181,543977.94768.841,237
Accrued Expenses
491.44494.15711.532,6412,0472,180
Short-Term Debt
1,5001,0005,3192,000700877.56
Current Portion of Long-Term Debt
4,6887502,1254,3501,500-
Current Portion of Leases
273.46257.16152.28140.83175.61172.18
Current Income Taxes Payable
---377.59--
Other Current Liabilities
600.06710.73547.67124.03122.82111.31
Total Current Liabilities
8,7154,53010,39810,6115,3154,578
Long-Term Debt
13,50018,12516,37515,50019,85020,550
Long-Term Leases
149.33295.4340.3638.45126.51302.12
Pension & Post-Retirement Benefits
----194.65521.28
Other Long-Term Liabilities
288.41279.04127.98122.51130.67-0
Total Liabilities
22,65223,23026,94226,27225,61625,952
Common Stock
1,9001,9001,9001,9001,9001,900
Additional Paid-In Capital
3,0853,0853,0853,0853,0853,085
Retained Earnings
27,07527,00529,20430,69328,85928,167
Comprehensive Income & Other
3,1603,1603,1603,1603,1603,160
Shareholders' Equity
35,21935,14937,34938,83737,00436,311
Total Liabilities & Equity
57,87258,37964,29065,10962,62062,263
Total Debt
20,11020,42824,01122,02922,35221,902
Net Cash (Debt)
-11,873-11,374-12,284-9,170-12,418-11,850
Net Cash Per Share
-3124.39-2993.19-3232.58-2413.27-3267.79-3118.43
Filing Date Shares Outstanding
3.83.83.83.83.83.8
Total Common Shares Outstanding
3.83.83.83.83.83.8
Working Capital
15,94719,11118,31918,07918,40719,179
Book Value Per Share
9268.259249.839828.5910220.379737.799555.62
Tangible Book Value
34,86434,79536,99238,48336,64735,953
Tangible Book Value Per Share
9174.799156.479734.7010127.009644.039461.40
Land
2,9822,9822,9822,9825,3355,335
Buildings
15,59916,02616,59617,16717,74117,791
Machinery
11,48212,3229,44910,67910,44011,114
Construction In Progress
74.3574.352,9092,3022,038580.63
Source: S&P Global Market Intelligence. Standard template. Financial Sources.